The single-test solution now enables clinicians to detect major RNA viruses such as Influenza strains, Respiratory Syncytial Virus (RSV), and Adenovirus, alongside bacterial and fungal pathogens, all through a single-test
Read MoreThe event, dedicated to driving clinical excellence, advancing oncological research, and improving patient care, served as a platform for collaboration and knowledge-sharing in the fight against cancer
Read MoreUnlike traditional tissue biopsies, which are invasive and can offer limited snapshots of tumour composition, liquid biopsies involve analysing circulating tumour DNA (ctDNA) and other cancer-related biomarkers in the blood
Read MoreA standout feature of the Radixact X9 is the Auto Beam Hold, which pauses radiation delivery if the patient moves beyond the tolerance limit during treatment, enhancing both safety and precision
Read MoreAs of 2024, the World Health Organization (WHO) estimates that over 19 million new cancer cases occur annually, with over 10 million cancer-related deaths
Read More